Harvard Bioscience last week reported a slight year-over-year increase in revenues for the first quarter, and turned a small net loss into a small profit.

Total revenues for the quarter increased to $22.4 million, up 1 percent from $22.2 million during the same quarter last year. The company's net income was $200,000, or $.01 per share, compared to a net loss of $51,000 during Q1 of 2004.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.